SecBot SecBot
8-K ·Filed Jul 23, 2026

TMO

THERMO FISHER SCIENTIFIC INC.
BULLISH
Impact 7/10
Horizondays Processed3mo ago SEC0000097745-26-000138
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The 5% organic growth acceleration and 90bps adjusted operating margin expansion are the key signals, they confirm end-market recovery and operational leverage. The stock should gap up on the beat; watch the 8:30am ET call for 2026 guidance updates, which could drive further upside if raised.

DirectionBullish
Confidencehigh
Horizondays

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$572.32
T+0 close · Jul 23, 2026 · via day close
Latest settled
+21.70%
T+60 · $696.49
Vs SPY
+17.14%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 23 $572.32entry
  2. T+1 · 4mo ago −0.71%α −0.81% · $568.26
  3. T+5 · 4mo ago +0.78%α +0.30% · $576.77
  4. T+20 · 3mo ago +9.65%α +6.34% · $627.55
  5. T+60 · 5w ago +21.70%α +17.14% · $696.49
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Thermo Fisher reported Q2 2026 revenue of $11.99B (+10% YoY) and adjusted EPS of $6.03 (+13% YoY), beating consensus estimates of $5.71. Organic revenue growth accelerated to 5% from 1% in Q1, with all four segments contributing to the upside. The company did not provide updated guidance in the release, but the strong beat and accelerating organic growth signal improving end-market conditions for this life sciences tools leader.

Key Financial Metrics

EPS
$6.03
est $5.71 · +5.6%
Revenue
$12.0B
est $11.7B · +2.5% · +10.5% YoY
Rating
beat
Free Cash Flow
$1.7B
Gross Margin
41.2%

Key Facts

  • Revenue grew 10% YoY to $11.99B, beating consensus of $11.70B
  • Adjusted EPS of $6.03 beat consensus of $5.71 by 5.6%
  • Organic revenue growth accelerated to 5% from 1% in Q1 2026
  • GAAP operating margin expanded 50bps YoY to 17.4%; adjusted operating margin expanded 90bps to 22.8%
  • Free cash flow surged 52% YoY to $1.68B in Q2
  • All four segments posted YoY revenue growth, led by Life Sciences Solutions (+13%) and Lab Products & Biopharma Services (+12%)
  • Company repurchased $1.0B of stock during the quarter
  • Guidance to be provided on the conference call, no update in the press release

Financial Impact

Revenue beat consensus by ~$290M (2.5%); adjusted EPS beat by $0.32 (5.6%)

revenueepsoperating marginfree cash flow

Risk Factors

  • No updated 2026 guidance provided in the release, conference call commentary is the next catalyst
  • GAAP operating cash flow declined sequentially from Q1 ($1.19B to $1.13B on a standalone Q2 basis), though H1 total is strong
  • Restructuring costs of $98M in Q2 vs $82M a year ago, elevated but manageable

Market Snapshot

Price
$577.78
Volume
40
Exchange
NYSE
Sector
Measuring & Controlling Devices, NEC
Analyst Consensus
81% bullish (36 analysts)

Investment Themes

Industrials & Manufacturing

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000097745-26-000138
Document: tmo-20260723.htm0000097745-26-000138
Document: 0000097745-26-000138-index-headers.html0000097745-26-000138
Document: 0000097745-26-000138-index.html0000097745-26-000138
Document: 0000097745-26-000138.txt0000097745-26-000138
8-K Data (Synthetic)0000097745-26-000138

Track record

21 reports on TMO

Performance horizon

2 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +29.04% at T+60 after the Jun 11, 2026 report. 3 of 5 went positive at some point.

Filters
  1. Nov 13, 20263d ago 144 Neutral 2/10 Entry $700.22 Now $691.33 −1.27% settles Feb 11
  2. Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $676.94 Now $691.33 +2.13% settles Feb 3
  3. Oct 30, 202617d ago 8-K Neutral 2/10 Entry $682.65 Now $691.33 +1.27% settles Jan 29
  4. Oct 28, 202619d ago 144 Neutral 2/10 Entry $709.18 Now $691.33 −2.52% settles Jan 27
  5. Oct 21, 202626d ago 8-K Bullish 7/10 Entry $694.02 Now $691.33 −0.39% settles Jan 19
  6. Oct 16, 20264w ago Institutional Cluster Neutral 3/10 Entry $690.00 Now $691.33 +0.19% settles Jan 13
  7. Sep 1, 202610w ago Insider Cluster Neutral 2/10 Entry $608.54 Now $691.33 +13.60% settles Nov 27
  8. Aug 26, 202611w ago Insider Cluster Neutral 2/10 Entry $630.70 Now $691.33 +9.61% settles Nov 20
  9. Aug 24, 202612w ago Insider Cluster Neutral 2/10 Entry $628.15 Now $691.33 +10.06% settles Nov 18
  10. Aug 18, 202613w ago Court Ruling Neutral 1/10 Entry $613.07 to $717.71 Now $691.33 +12.77% ▲ +17.07% +17.89% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 7h 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 23, 2026